The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells

Authors: Shiguo Zhu, Cecele J. Denman, Zehra S. Cobanoglu, Simin Kiany, Ching C. Lau, Stephen Gottschalk, Dennis P.M. Hughes, Eugenie S. Kleinerman, Dean A. Lee - Pharmaceutical Research 2013 cited by 107